Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2/PHASE3
INTERVENTIONAL
2016-06-30
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Ultrasound Guidance to Facilitate Obtaining Peripheral Intravenous Access
NCT04877301
Study to Determine Pediatric Bladder Volume Prior to Catheterization
NCT00847392
Recent Techniques for Diagnosing Central Venous Catheter-related Bloodstream Infections in Children
NCT01249976
Prevention of Renal Failure in Children With Urinary Tract Infections
NCT00316043
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants
NCT03801213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antiseptic-coated catheter
Hydrophilic intermittent urinary catheter coated with octenidine chloride
Antiseptic-coated catheter
Antiseptic-coated hydrophilic intermittent urinary catheter with octenidine chloride
Octenidine chloride
Antiseptic
Hydrophilic catheter
Hydrophilic intermittent urinary catheter
Hydrophilic catheter
Hydrophilic intermittent urinary catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antiseptic-coated catheter
Antiseptic-coated hydrophilic intermittent urinary catheter with octenidine chloride
Hydrophilic catheter
Hydrophilic intermittent urinary catheter
Octenidine chloride
Antiseptic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* use of intermittent catheterisation for neurogenic bladder management
* informed oral and written consent from the child and both parents/legal guardian
Exclusion Criteria
* Immunodeficiency
* Urinary tract fistula
1 Month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GuardianMed j.d.o.o. Research and development in medicine
UNKNOWN
Children's Hospital Zagreb
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Slaven Abdovic, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Zagreb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Zagreb
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GCath-CHZ-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.